ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
0.00%
Bitcoin
68,129.15
0.60%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cymabay Therapeutics Inc (CBAY)

  7. Cymabay Therapeutics Inc (CBAY) News

CBAY

Cymabay Therapeutics (CBAY)

Cymabay Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CBAY
DateTimeSourceHeadlineSymbolCompany
03/22/20248:18AMBusiness WireGilead Sciences Announces Completion of Acquisition of CymaBayNASDAQ:CBAYCymabay Therapeutics Inc
03/11/20248:14AMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
03/07/20243:35PMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
02/28/20244:01PMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
02/23/20245:25AMEdgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:CBAYCymabay Therapeutics Inc
02/16/20244:14PMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CBAYCymabay Therapeutics Inc
02/15/20243:15PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
02/14/20245:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
02/14/20243:46PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
02/14/202411:50AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CBAYCymabay Therapeutics Inc
02/14/20248:09AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
02/13/20243:27PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
02/12/20244:29PMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CBAYCymabay Therapeutics Inc
02/12/20243:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
02/12/202412:43PMPR Newswire (US)Kuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to Contact Law FirmNASDAQ:CBAYCymabay Therapeutics Inc
02/12/20247:45AMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CBAYCymabay Therapeutics Inc
02/12/20247:42AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CBAYCymabay Therapeutics Inc
02/06/20244:38PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
02/01/20244:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
01/30/20245:33PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
01/29/20244:59PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
01/26/20245:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
01/26/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
01/26/20245:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
01/26/20245:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
01/26/20245:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
01/26/20245:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
01/26/20245:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
01/26/20245:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
01/26/20245:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CBAY

Your Recent History

LSE
XMJU
Xmsci Japan 1d
COIN
XMRUSD
Monero
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved